title: Re: Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder: H. W. Chen, R. S. Bercik, E. F. Werner And S. F. Thung; J Urol 2012; 187: 178-184.
authors.forename: Ronald P
authors.initials: RP
authors.lastname: Kaufman
mesh_terms: D001559:Benzhydryl Compounds / Q000191:economics* / Q000627:therapeutic use*; D003408:Cresols / Q000191:economics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018727:Muscarinic Antagonists / Q000191:economics* / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000191:economics* / Q000627:therapeutic use*; D004561:Transcutaneous Electric Nerve Stimulation / Q000191:economics*; D053201:Urinary Bladder, Overactive / Q000191:economics* / Q000628:therapy*
chemical_list: D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine